Effect of graft perfusion with two CD45 monoclonal antibodies on incidence of kidney allograft rejection
Y Brewer, D Taube, M Bewick, G Hale, F Dische… - The Lancet, 1989 - Elsevier
Y Brewer, D Taube, M Bewick, G Hale, F Dische, A Palmer, K Welsh, C Bindon, H Waldmann…
The Lancet, 1989•ElsevierIn a blind trial, 77 patients were randomised to receive first cadaver kidney allografts that
had been perfused either with a pair of CD45 monoclonal antibodies (mAbs), in an attempt
to reduce the immunogenicity of passenger leucocytes, or with control human albumin
solution. No complications of mAb perfusion were observed. Patient and allograft survival
were similar in both groups. Rejection episodes were recorded in 7 (18%) of the patients
with mAb perfused allografts compared with 24 (63%) of the controls.
had been perfused either with a pair of CD45 monoclonal antibodies (mAbs), in an attempt
to reduce the immunogenicity of passenger leucocytes, or with control human albumin
solution. No complications of mAb perfusion were observed. Patient and allograft survival
were similar in both groups. Rejection episodes were recorded in 7 (18%) of the patients
with mAb perfused allografts compared with 24 (63%) of the controls.
Abstract
In a blind trial, 77 patients were randomised to receive first cadaver kidney allografts that had been perfused either with a pair of CD45 monoclonal antibodies (mAbs), in an attempt to reduce the immunogenicity of passenger leucocytes, or with control human albumin solution. No complications of mAb perfusion were observed. Patient and allograft survival were similar in both groups. Rejection episodes were recorded in 7 (18%) of the patients with mAb perfused allografts compared with 24 (63%) of the controls.
Elsevier